Richard Pzena’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,049
Closed -$317K – 164
2026
Q2
$317K Hold
4,049
– – ﹤0.01% 147
2026
Q1
$262K Sell
4,049
-229
-5% -$16.1K ﹤0.01% 152
2025
Q4
$288K Buy
4,278
+171
+4% +$11.5K ﹤0.01% 152
2025
Q3
$301K Buy
+4,107
New +$273K ﹤0.01% 144
2023
Q2
– Sell
-9,216
Closed -$352K – 165
2023
Q1
$352K Sell
9,216
-5,291
-36% -$248K ﹤0.01% 153
2022
Q4
$825K Buy
+14,507
New +$743K ﹤0.01% 140
2022
Q2
– Sell
-15,738
Closed -$628K – 172
2022
Q1
$628K Buy
+15,738
New +$561K ﹤0.01% 146

Other funds holding HALO

Richard Pzena's HALO Position: Q3 2026 in Review

Richard Pzena sold out of Halozyme (HALO) in Q3 2026, closing a stake of 4,049 shares — an estimated $317K sold.

Richard Pzena first reported a position in HALO in Q1 2022 and held it in 7 quarters. The position peaked at $825K in Q4 2022. 773 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Richard Pzena reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • Richard Pzena sold 4,049 Halozyme shares in Q3 2026, an estimated $317K.
  • Richard Pzena first reported a position in Halozyme in Q1 2022 and held it in 7 quarters.
  • Richard Pzena's Halozyme position peaked at $825K in Q4 2022.
  • 773 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Pzena Investment Management's 13F filing for Q3 2026, filed 30 Oct 2026.